GO:0000341 RNA trimethylguanosine cap binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000341 RNA trimethylguanosine cap binding describes the molecular function of recognizing the m3(2,2,7)GTP cap at the 5' end of certain RNAs, including snRNAs, snoRNAs, and some mRNAs.
• The trimethylguanosine (TMG) cap is produced by posttranscriptional hypermethylation of a 7-methylguanosine cap, a process conserved from yeast to humans.
• Key proteins that bind the TMG cap include snurportin1 (SNUPN), nuclear cap-binding proteins, and the U1 snRNP subunit Snp1, as well as translation initiation factor eIF4E in some contexts.
• Loss of TMG cap binding affects snRNP and snoRNP assembly, pre-mRNA splicing, and ribosome biogenesis, with cold-sensitive phenotypes in yeast.
• TMG cap structures have been found on a subset of mRNAs in Caenorhabditis elegans, suggesting broader roles in gene expression.
• Dysregulation of TMG cap metabolism is linked to viral RNA processing and potential cancer-related translation bypass mechanisms.
Description
RNA trimethylguanosine cap binding (GO:0000341) is a molecular function that enables proteins to specifically recognize and bind the 2,2,7-trimethylguanosine (m3(2,2,7)GTP) cap structure at the 5' end of certain RNA molecules. This cap is a posttranscriptional modification of the standard 7-methylguanosine (m7G) cap and is predominantly found on small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs) transcribed by RNA polymerase II, and also on some snRNAs transcribed by RNA polymerase III. The trimethylguanosine cap serves as a nuclear localization signal and a binding platform for proteins involved in RNA processing, stability, and function. Researchers study this term to understand how RNA-protein interactions govern splicing, ribosome biogenesis, and translation, and how their dysregulation contributes to disease. The binding event is critical for the assembly and nuclear import of snRNPs and snoRNPs, and it influences the fate of capped RNAs in the cell.
RNA trimethylguanosine cap binding At A Glance
| GO ID | GO:0000341 |
|---|---|
| GO term | RNA trimethylguanosine cap binding |
| Ontology | molecular_function |
| Synonym | RNA m2,2,7G cap binding |
| Major function | Binding to the trimethylguanosine cap at the 5' end of RNA molecules, facilitating RNA processing, nuclear import, and translation regulation. |
| Cap structure | m3(2,2,7)GTP (2,2,7-trimethylguanosine triphosphate) cap. |
| Common RNA targets | snRNAs, snoRNAs, and a subset of mRNAs in some species. |
| Key binding proteins | Snurportin1 (SNUPN), nuclear cap-binding proteins, eIF4E, and U1 snRNP subunit Snp1. |
| Related processes | snRNP assembly, snoRNP assembly, pre-mRNA splicing, ribosome biogenesis, and translation initiation. |
What Is GO:0000341?
RNA trimethylguanosine cap binding is the molecular function of selectively binding to the trimethylguanosine (m3(2,2,7)GTP) group located at the 5' end of some RNA molecules. This cap structure is generally produced by posttranscriptional modification of a 7-methylguanosine cap and is often found on snRNAs and snoRNAs transcribed by RNA polymerase II, but has also been found on snRNAs transcribed by RNA polymerase III, and on a subset of mRNAs in some species such as C. elegans.
Why Is RNA trimethylguanosine cap binding Important in Cell Biology?
Understanding RNA trimethylguanosine cap binding is essential because it governs fundamental RNA metabolic pathways, including splicing and ribosome biogenesis, and it serves as a regulatory checkpoint for gene expression. The TMG cap and its binding proteins are conserved across eukaryotes, and their dysfunction has been linked to defects in snRNP assembly, cold sensitivity in yeast, and altered translation in viral infections and cancer. Moreover, the discovery of TMG caps on specific mRNAs in C. elegans suggests that this modification may expand the regulatory repertoire of transcripts beyond non-coding RNAs. Studying this function provides insights into RNA-protein interaction networks and offers potential therapeutic targets for diseases where RNA processing is perturbed.
• Essential for snRNP and snoRNP assembly and nuclear import.
• Influences pre-mRNA splicing by ensuring proper U1 snRNP function.
• Required for ribosome biogenesis through snoRNP-mediated rRNA processing.
• Acts as a nuclear localization signal for capped RNAs.
• Modulates translation initiation via cap-binding proteins like eIF4E.
• Implicated in viral RNA processing and immune evasion.
• Potential role in cancer through m7G-cap hypermethylation and translation bypass.
• Provides a model for studying RNA modification and epitranscriptomics.
• Conserved from yeast to humans, enabling genetic studies.
• Target for chemical biology tools such as fluorescent molecular rotors.
What Happens During RNA trimethylguanosine cap binding?
Cap Recognition and Binding
In simple terms: Proteins recognize the special trimethylguanosine cap on RNA and attach to it.
The process begins with the specific recognition of the m3(2,2,7)GTP cap structure by cap-binding proteins. Snurportin1 (SNUPN) is a dedicated import adaptor that binds the TMG cap with high specificity, as demonstrated by fluorescent molecular rotor conjugates that visualize this interaction in living cells. Nuclear cap-binding proteins also interact with the TMG cap, and in yeast, the nuclear cap-binding protein Cbc2p becomes a gained U1 component in the absence of trimethylguanosine caps. The binding is mediated by structural elements that accommodate the three methyl groups on the guanosine moiety, distinguishing it from the monomethylated m7G cap.
snRNP and snoRNP Assembly
In simple terms: After binding, the cap helps assemble small nuclear ribonucleoproteins (snRNPs) and small nucleolar ribonucleoproteins (snoRNPs).
Once bound, the TMG cap serves as a platform for the assembly of snRNPs and snoRNPs. In yeast, the absence of trimethylguanosine caps leads to altered composition of snRNPs and snoRNPs, with the nuclear cap-binding protein becoming a component of U1 snRNP, which is implicated in the cold-sensitivity of tgs1Δ cells. This assembly is critical for the maturation and function of these ribonucleoprotein complexes, which are essential for splicing and rRNA processing.
Nuclear Import and Localization
In simple terms: The cap-binding complex helps transport the RNA into the nucleus.
The TMG cap acts as a nuclear localization signal. Snurportin1 binds the cap and interacts with importin-β to mediate nuclear import of snRNPs. This import pathway is conserved and ensures that snRNPs reach the nucleus where they function in splicing. Disruption of this binding affects the subcellular distribution of snRNPs and can lead to defects in splicing.
Regulation of Splicing and Translation
In simple terms: The cap binding influences how RNA is spliced and translated.
Binding of the TMG cap affects downstream processes such as pre-mRNA splicing and translation. In yeast, genetic suppression of RNA trimethylguanosine cap deficiency occurs via C-terminal truncation of U1 snRNP subunit Snp1 or overexpression of RNA polymerase subunit Rpo26, linking cap binding to splicing efficiency. Additionally, eIF4E can bind the trimethylguanosine cap, and structural changes in eIF4E upon binding to m7G or TMG caps have been characterized, suggesting a role in translation initiation. In viruses, m7G-cap hypermethylation and nuclear cap-binding proteins can bypass suppression of eIF4E-dependent translation.
Key Genes Involved in GO:0000341 RNA trimethylguanosine cap binding
The following genes and proteins are central to RNA trimethylguanosine cap binding and its associated processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SNUPN (snurportin1) | Binds the TMG cap and mediates nuclear import of snRNPs | Target for fluorescent probes and structural studies |
| TGS1 | Catalyzes hypermethylation of m7G cap to TMG cap | Yeast tgs1Δ mutants show cold sensitivity and snRNP defects |
| CBC2 (Cbc2p) | Nuclear cap-binding protein; gained U1 component in tgs1Δ | Studied for its role in snRNP composition |
| SNP1 | U1 snRNP subunit; truncation suppresses TMG cap deficiency | Genetic suppressor of tgs1Δ cold sensitivity |
| RPO26 | RNA polymerase subunit; overexpression suppresses TMG cap deficiency | Suppressor of TMG cap defects |
| EIF4E | Translation initiation factor; binds m7G and TMG caps | Structural studies of cap binding |
| U1 snRNP | Splicing machinery; requires TMG cap for assembly | Model for splicing defects |
| SnoRNPs | Ribosome biogenesis; contain TMG-capped snoRNAs | Studied for rRNA processing |
| Importin-β | Nuclear import receptor; interacts with snurportin1 | Component of nuclear import pathway |
| C. elegans TMG-capped mRNAs | Subset of mRNAs with TMG caps | Model for mRNA modification |
| HIV-1 RNA | Viral RNA with cap methylation | Viral translation regulation |
| m7G-cap hypermethylation enzymes | Generate TMG caps on viral and cellular RNAs | Cancer and viral translation bypass |
How Is RNA trimethylguanosine cap binding Regulated?
The RNA trimethylguanosine cap binding function is regulated at multiple levels. The availability of the TMG cap itself is controlled by the enzyme Tgs1, which hypermethylates the m7G cap; in its absence, cells exhibit cold sensitivity and altered snRNP composition. The expression and activity of cap-binding proteins such as snurportin1 and nuclear cap-binding proteins are also regulated, affecting the efficiency of snRNP import and assembly. Additionally, viral factors can modulate cap methylation to bypass eIF4E-dependent translation, as seen in HIV-1 and other viruses. This regulation ensures proper RNA processing and responds to cellular stress and viral infection.
RNA trimethylguanosine cap binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGS1 | snRNP assembly defects, cold sensitivity | Yeast tgs1Δ knockout and point mutants |
| SNUPN | Nuclear import defects, potential splicing disorders | Human cell lines with SNUPN knockout or tagged knock-in |
| EIF4E | Translation dysregulation in cancer | Cancer cell lines with eIF4E overexpression or point mutations |
| HIV-1 RNA | Viral translation and immune evasion | HIV-1 infected cells with cap methylation inhibitors |
| C. elegans TMG-capped mRNAs | mRNA modification and gene expression | C. elegans models with tagged TMG-binding proteins |
Viral Infections and Immune Evasion
Viruses such as HIV-1 exploit cap methylation and TMG cap-binding proteins to regulate their RNA processing and translation. m7G-cap hypermethylation and nuclear cap-binding proteins can bypass the suppression of eIF4E-dependent translation, allowing viral transcripts to be translated efficiently even when host translation is shut down. This mechanism contributes to viral replication and immune evasion, making cap-binding proteins potential antiviral targets.
Cancer and Translation Dysregulation
Emerging roles of m7G-cap hypermethylation and nuclear cap-binding proteins in bypassing eIF4E-dependent translation have been implicated in cancer. Tumor cells may utilize TMG cap-binding pathways to sustain translation of oncogenic mRNAs under stress conditions, promoting survival and proliferation. Targeting these pathways could offer new therapeutic strategies for cancers resistant to conventional translation inhibitors.
Genetic Disorders of RNA Processing
Defects in TMG cap formation or binding can lead to impaired snRNP assembly and splicing, which are associated with genetic disorders such as retinitis pigmentosa and spinal muscular atrophy, though direct links to TMG cap binding require further study. Model organisms like yeast have been instrumental in uncovering these connections, revealing cold-sensitive phenotypes and splicing defects when TMG cap binding is compromised.
From RNA trimethylguanosine cap binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of TMG cap binding loss on splicing? | Knockout of TGS1 or SNUPN in yeast or human cells |
| How does a point mutation in the cap-binding pocket affect RNA import? | Point mutation in SNUPN cap-binding domain |
| Can a tagged cap-binding protein visualize TMG caps in live cells? | Knock-in of fluorescent tag into SNUPN or CBC2 |
| Does overexpression of a cap-binding protein rescue TMG deficiency? | Overexpression of RPO26 or SNP1 truncation |
| What mRNAs carry TMG caps in C. elegans? | Overexpression of TMG-binding proteins followed by RNA-seq |
| How does cap methylation affect viral translation? | Knockout of cap methyltransferases in HIV-1 infected cells |
How to Study the RNA trimethylguanosine cap binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RIP-seq | RNAs bound by TMG cap or cap-binding proteins | Transcriptome-wide mapping of TMG-capped RNAs |
| TMG-FMR imaging | Real-time cap binding in live cells | Visualization of snurportin1-TMG interactions |
| NMR spectroscopy | Structural changes upon cap binding | eIF4E cap recognition |
| Yeast genetics | Suppressors of TMG cap deficiency | Identification of Snp1 and Rpo26 suppressors |
| Mass spectrometry | Cap structure composition | Detection of TMG caps on snRNAs |
| CRISPR knockout | Loss-of-function phenotypes | TGS1 or SNUPN knockout in cell lines |
| Proteomics | Cap-binding protein complexes | snRNP assembly studies |
RNA Immunoprecipitation and Sequencing (RIP-seq)
RIP-seq using antibodies against TMG cap or tagged cap-binding proteins can identify RNAs associated with TMG cap binding. This method has been used to systematically identify non-coding RNA 2,2,7-trimethylguanosine cap structures in C. elegans. It provides a transcriptome-wide view of TMG-capped RNAs and their binding partners.
Fluorescent Molecular Rotors and Imaging
Trimethylguanosine cap-fluorescent molecular rotor (TMG-FMR) conjugates are potent, specific snurportin1 ligands that enable visualization of TMG cap binding in living cells. This technique allows real-time monitoring of cap-binding dynamics and subcellular localization.
Structural Biology (NMR, X-ray, Cryo-EM)
Structural studies of eIF4E upon binding to m7G and TMG caps have revealed conformational changes that underlie cap recognition. Similar approaches can be applied to other cap-binding proteins to understand specificity and affinity.
Genetic Suppression and Yeast Genetics
Yeast genetics has been instrumental in identifying suppressors of TMG cap deficiency, such as C-terminal truncation of Snp1 or overexpression of Rpo26. These studies link cap binding to splicing and cold sensitivity, providing functional insights.
How CRISPR Can Be Used to Study GO:0000341 RNA trimethylguanosine cap binding
Knockout
CRISPR knockout of genes encoding TMG cap-binding proteins or modifying enzymes, such as TGS1 or SNUPN, can reveal loss-of-function phenotypes in RNA processing and splicing. For example, yeast tgs1Δ mutants exhibit cold sensitivity and altered snRNP composition. In human cells, knockout of SNUPN can impair nuclear import of snRNPs.
Point Mutation
Point mutations in the cap-binding domain of SNUPN or EIF4E can be introduced using CRISPR base editing or homology-directed repair to dissect the structural requirements for TMG cap recognition. Such mutations can abolish binding without affecting protein stability, as shown for eIF4E cap-binding mutants.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous SNUPN or CBC2 loci allows live-cell imaging of TMG cap-binding proteins. This approach has been validated by TMG-FMR conjugates that visualize snurportin1 in living cells. Tagged knock-ins can also be used for proteomic analysis of cap-binding complexes.
Overexpression
Overexpression of TMG cap-binding proteins or their regulators can rescue deficiency phenotypes or amplify cap-binding activity. For instance, overexpression of Rpo26 suppresses TMG cap deficiency in yeast. In mammalian cells, overexpression of eIF4E can enhance translation of TMG-capped mRNAs.
How EDITGENE Supports RNA trimethylguanosine cap binding Research
Researchers studying RNA trimethylguanosine cap binding-related genes often need to determine whether a candidate gene is causally involved in RNA processing, splicing, or translation. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for RNA trimethylguanosine cap binding research.
Frequently Asked Questions About RNA trimethylguanosine cap binding
What is RNA trimethylguanosine cap binding?
RNA trimethylguanosine cap binding (GO:0000341) is the molecular function of binding to the m3(2,2,7)GTP cap at the 5' end of certain RNAs, such as snRNAs and snoRNAs.
What genes are involved in RNA trimethylguanosine cap binding?
Key genes include SNUPN (snurportin1), TGS1, CBC2, SNP1, RPO26, and EIF4E, which encode proteins that bind or modify the TMG cap.
How is the trimethylguanosine cap formed?
The TMG cap is formed by posttranscriptional hypermethylation of a 7-methylguanosine cap, catalyzed by the enzyme Tgs1.
What RNAs carry a trimethylguanosine cap?
snRNAs and snoRNAs transcribed by RNA polymerase II, some snRNAs transcribed by RNA polymerase III, and a subset of mRNAs in species like C. elegans.
What is the function of snurportin1 in TMG cap binding?
Snurportin1 binds the TMG cap and mediates nuclear import of snRNPs, acting as an import adaptor.
How does TMG cap binding affect splicing?
TMG cap binding is required for proper snRNP assembly and U1 snRNP function; its deficiency can cause splicing defects and cold sensitivity in yeast.
Can TMG cap binding be visualized in live cells?
Yes, trimethylguanosine cap-fluorescent molecular rotor conjugates enable specific visualization of snurportin1 and TMG cap binding in living cells.
What diseases are linked to TMG cap binding?
Dysregulation is implicated in viral infections, cancer translation bypass, and genetic disorders of RNA processing.
How can I study TMG cap binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of TMG cap-binding proteins in RNA processing.
What methods identify TMG-capped RNAs?
RIP-seq, mass spectrometry, and fluorescent imaging are commonly used to identify and visualize TMG-capped RNAs and their binding proteins.
Conclusion
RNA trimethylguanosine cap binding (GO:0000341) is a fundamental molecular function that governs the fate of snRNAs, snoRNAs, and some mRNAs by mediating their recognition, assembly into ribonucleoprotein complexes, and nuclear import. Its roles in splicing, ribosome biogenesis, and translation regulation are conserved across eukaryotes, and its dysregulation is linked to viral infections and cancer. Continued research using CRISPR models and advanced imaging will further illuminate the mechanistic details and therapeutic potential of this cap-binding function.
References
- 1. Boris-Lawrie K et al.. 2022. Anomalous HIV-1 RNA, How Cap-Methylation Segregates Viral Transcripts by Form and Function.. Viruses 14(5) PMID: 35632676
- 2. Jia D et al.. 2007. Systematic identification of non-coding RNA 2,2,7-trimethylguanosine cap structures in Caenorhabditis elegans.. BMC Mol Biol 8:86 PMID: 17903271
- 3. Surynt P et al.. 2024. Trimethylguanosine cap-fluorescent molecular rotor (TMG-FMR) conjugates are potent, specific snurportin1 ligands enabling visualization in living cells.. Org Biomol Chem 22(33):6763-6790 PMID: 39105613
- 4. Rutkowska-Wlodarczyk I et al.. 2008. Structural changes of eIF4E upon binding to the mRNA 5' monomethylguanosine and trimethylguanosine Cap.. Biochemistry 47(9):2710-20 PMID: 18220364
- 5. Qiu ZR et al.. 2015. Two Routes to Genetic Suppression of RNA Trimethylguanosine Cap Deficiency via C-Terminal Truncation of U1 snRNP Subunit Snp1 or Overexpression of RNA Polymerase Subunit Rpo26.. G3 (Bethesda) 5(7):1361-70 PMID: 25911228
- 6. Gerbi SA. 1995. Small nucleolar RNA.. Biochem Cell Biol 73(11-12):845-58 PMID: 8722000
- 7. Boris-Lawrie K et al.. 2025. Emerging Roles of m7G-Cap Hypermethylation and Nuclear Cap-Binding Proteins in Bypassing Suppression of eIF4E-Dependent Translation.. Viruses 17(3) PMID: 40143300
- 8. Schwer B et al.. 2011. Composition of yeast snRNPs and snoRNPs in the absence of trimethylguanosine caps reveals nuclear cap binding protein as a gained U1 component implicated in the cold-sensitivity of tgs1Δ cells.. Nucleic Acids Res 39(15):6715-28 PMID: 21558325
